Articles

Glaucoma and ocular hypertension (OHT) patients are highly satisfied with ocular hypertensives, claims a recent investigation.

The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK data is unavailable.

Monthly intravitreal aflibercept significantly improves visual acuity (VA) in patients with macular oedema secondary to central retinal vein occlusion (CRVO), according to the latest phase of the COPERNICUS study.

The UK Vision Strategy has opened a call for posters and abstracts for the Vision UK 2013 conference.

Low doses of clobetasone butyrate drops are safe and effective for Sj?gren syndrome (SS), claims an investigation.

Bevacizumab could play a role in treating Coats' disease, claims a recent study.

Loteprednol etabonate controls inflammation and reduces IOP fluctuation after cataract surgery, according to a recent study.

Beclomethasone nasal spray doesn't increase IOP in patients with ocular hypertension and primary open-angle glaucoma, reveals a study in the Journal of Glaucoma.

Indocyanine green (ICG) enhanced transpupillary thermotherapy (TTT) in combination with ophthalmic artery chemosurgery can effectively treat retinoblastoma refractory without ocular side effects, claims a study.

Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.

Ivantis announced the completion of financing $27 million for a novel glaucoma procedure at the Glaucoma Research Foundation's latest meeting.

Geuder has announced its support for ophthalmic clinic CEPRECE, based in Cusco, Peru.

Anti-VEGF therapy doesn?t not significantly affect visual acuity and metamorphopsia in patients treated for retinal pigment epithelium tears in eyes, according to a paper featured in Retina.

Optical biometry provides more repeatable and precise measurements of biometric parameters in highly myopic eyes, states a recent study.

Optos is urging skiers to ensure they take care of their eyesight while on the slopes this winter, according to their latest press release.

Loteprednol etabonate gel 0.5% is efficacious and safe for treating postoperative inflammation and pain caused by cataract surgery, claims a recent report.

Ozurdex could have a beneficial effect on the visual prognosis in branch retinal vein occlusion (BRVO), reveals a study in Eye.

Adalimumab is an effective treatment for patients with active non-infectious uveitis, according to a recent investigation.

Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

Autofluorescence (AF) and spectral domain optical coherence tomography (SD-OCT) can detect structural abnormalities in patients with autoimmune retinopathy (AIR), according to a recent study.

Catatrac may be a low-cost and effective tool for the rapid screening of visually significant cataracts in the developing world, claims a paper in the journal Eye.

The Visions of Gullstrand ophthalmology congress, 31 May to 2 June 2013, is now open for registration.

Subconjunctival mitomycin C (MMC) injections followed by bare sclera pterygium excision is successful and cost-effective for the treatment of recurrent pterygium associated with symblepharon, according to a recently published study.

A new hydrophobic acrylic IOL is an effective, safe and predictable method for the correction of corneal astigmatism in patients undergoing routine cataract surgery.

Microperimetry may provide additional information on macula function that is not available using visual acuity data.

Preoperative povidone-iodine and postoperative intracameral antibiotic injections are recommended for endophthalmitis prophylaxis, claims a recent paper.

Minims Eye Drops Solution has been recalled in the UK only, reveals the latest statement from Bausch+Lomb.

Collagen cross-linking (CXL) can cause more intense postoperative pain in younger patients.

Ocular sebaceous carcinoma (OSC) has been confirmed as a rare cancer in the UK, claims a recent study.

Optegra has acquired Memira's eye clinics in Munich and Stuttgart, Germany.